ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
162 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
732
|
267K
|
162
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
24K |
12M |
22 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
24K
|
12M
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
28 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
732
|
267K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
85 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
732
|
267K
|
85
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
75 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
732
|
267K
|
75
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
42 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
732
|
267K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
39 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
732
|
267K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
1.7K |
598K |
44 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
1.7K
|
598K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
88 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
88
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
21K |
7.2M |
63 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
21K
|
7.2M
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Ann: First Patient Dosed in Phase 1b/2 AML Trial
|
|
Mason14
|
245 |
84K |
60 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
245
|
84K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
35 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
16 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
65 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
12 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Mason14
|
127 |
41K |
28 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
127
|
41K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
74 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
74
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Mason14
|
127 |
41K |
87 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
127
|
41K
|
87
|
|
ASX - By Stock
|
IIQ |
Re:
BD1O options - speculative scenarios
|
|
Mason14
|
73 |
27K |
20 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
73
|
27K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
26 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
118
|
40K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
54 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
82 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
82
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
49 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
118
|
40K
|
49
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.8M |
86 |
31/08/21 |
31/08/21 |
General
|
10K
|
3.8M
|
86
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
74 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
732
|
267K
|
74
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
35 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
732
|
267K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
16 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
732
|
267K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
94 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
732
|
267K
|
94
|
|
ASX - By Stock
|
CUF |
Re:
FEL CHART THREAD
|
|
Mason14
|
310 |
128K |
15 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
310
|
128K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
43 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
118
|
40K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
38 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
118
|
40K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
45 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
118
|
40K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race starts preclinical breast cancer study for Bisantrene
|
|
Mason14
|
118 |
40K |
61 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
118
|
40K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
732 |
267K |
91 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
732
|
267K
|
91
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
99 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
99
|
|
ASX - By Stock
|
IIQ |
Re:
BD1 Clinical Efficacy and Valuation Discussion
|
|
Mason14
|
16 |
10K |
33 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
16
|
10K
|
33
|
|
ASX - By Stock
|
CUF |
Re:
Ann: Corporate Presentation
|
|
Mason14
|
24 |
9.2K |
3 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
24
|
9.2K
|
3
|
|
ASX - By Stock
|
CUF |
Re:
Ann: Corporate Presentation
|
|
Mason14
|
24 |
9.2K |
10 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
24
|
9.2K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
52 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates FTO Melanoma Preclinical Study
|
|
Mason14
|
163 |
58K |
67 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
163
|
58K
|
67
|
|
ASX - By Stock
|
APT |
Re:
Ann: Square, Inc. announces plans to acquire Afterpay
|
|
Mason14
|
883 |
334K |
1 |
07/08/21 |
07/08/21 |
ASX - By Stock
|
883
|
334K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.8M |
147 |
06/08/21 |
06/08/21 |
General
|
10K
|
3.8M
|
147
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Mason14
|
48 |
16K |
35 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
48
|
16K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
30 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
30
|
|
ASX - By Stock
|
RTR |
Re:
$1
|
|
Mason14
|
17 |
11K |
11 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
17
|
11K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 trial advances following successful Phase 1b
|
|
Mason14
|
406 |
139K |
3 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
406
|
139K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
47 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
47
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 trial advances following successful Phase 1b
|
|
Mason14
|
406 |
139K |
4 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
406
|
139K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
106 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
2.9K
|
1.0M
|
106
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.8M |
110 |
31/07/21 |
31/07/21 |
General
|
10K
|
3.8M
|
110
|
|